3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
40
Triple Negative Breast Neoplasms
16
Carcinoma, Transitional Cell
14
Breast Neoplasms
14
Small Cell Lung Carcinoma
12
Urinary Bladder Neoplasms
11
Melanoma
10
Carcinoma, Hepatocellular
9
Neoplasms
8
Carcinoma, Renal Cell
8
Uterine Cervical Neoplasms
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Colorectal Neoplasms
5
Ovarian Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Stomach Neoplasms
2
Solid Tumors
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Kidney Neoplasms
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Interventions
Cisplatin
13
Radiotherapy, Intensity-Modulated
11
Radiotherapy
5
Carboplatin
5
Radiation
4
Cetuximab
4
durvalumab
3
Platinum
3
Nivolumab
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Specimen Handling
2
Restraint, Physical
2
Paclitaxel
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
Bupropion
2
Biopsy
2
Acupuncture Therapy
2
veliparib
1
utomilumab
1
sodium thiosulfate
1
ficlatuzumab
1
dehydroftorafur
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Oropharyngeal Neoplasms
×
atezolizumab
×
Clear all
No trials found.